nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A benchmark for management of drug resistant HIV
|
Pozniak, Anton L |
|
|
13 |
7 |
p. 561-562 |
artikel |
2 |
Alarm bells over MERS coronavirus
|
Bennet, Neil |
|
|
13 |
7 |
p. 573-574 |
artikel |
3 |
Behavioural research in epidemics
|
Atlani-Duault, Laëtitia |
|
|
13 |
7 |
p. 567-568 |
artikel |
4 |
Behavioural research in epidemics
|
Liao, Qiuyan |
|
|
13 |
7 |
p. 567 |
artikel |
5 |
Behavioural research in epidemics – Authors' reply
|
SteelFisher, Gillian K |
|
|
13 |
7 |
p. 568 |
artikel |
6 |
Boceprevir for HCV in patients with HIV: where next?
|
Osinusi, Anuoluwapo |
|
|
13 |
7 |
p. 563-564 |
artikel |
7 |
Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial
|
Sulkowski, Mark |
|
|
13 |
7 |
p. 597-605 |
artikel |
8 |
Co-infection: new battlegrounds in HIV/AIDS
|
The Lancet Infectious Diseases, |
|
|
13 |
7 |
p. 559 |
artikel |
9 |
Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries
|
Loyse, Angela |
|
|
13 |
7 |
p. 629-637 |
artikel |
10 |
Economics of monitoring antiretroviral therapy
|
Mermin, Jonathan |
|
|
13 |
7 |
p. 560-561 |
artikel |
11 |
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials
|
Eron, Joseph J |
|
|
13 |
7 |
p. 587-596 |
artikel |
12 |
Frequency and implications of HIV superinfection
|
Redd, Andrew D |
|
|
13 |
7 |
p. 622-628 |
artikel |
13 |
Infectious disease surveillance update
|
Boodhun, Nawsheen |
|
|
13 |
7 |
p. 574 |
artikel |
14 |
Inoculating communities against vaccine scare stories
|
Crowcroft, Natasha Sarah |
|
|
13 |
7 |
p. 564-565 |
artikel |
15 |
It sounds like a relapsing polychondritis
|
Belot, Alexandre |
|
|
13 |
7 |
p. 638 |
artikel |
16 |
Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines
|
Larson, Heidi J |
|
|
13 |
7 |
p. 606-613 |
artikel |
17 |
Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis
|
Boyer, Sylvie |
|
|
13 |
7 |
p. 577-586 |
artikel |
18 |
Panton-Valentine leucocidin and pneumonia
|
Diep, Binh An |
|
|
13 |
7 |
p. 566 |
artikel |
19 |
Panton-Valentine leucocidin and pneumonia – Authors' reply
|
Shallcross, Laura J |
|
|
13 |
7 |
p. 566-567 |
artikel |
20 |
Research brief
|
Bradbury, Jane |
|
|
13 |
7 |
p. 575 |
artikel |
21 |
Rifampicin and moxifloxacin for tuberculous meningitis
|
Ukwaja, Kingsley N |
|
|
13 |
7 |
p. 569-570 |
artikel |
22 |
Rifampicin and moxifloxacin for tuberculous meningitis
|
Akkerman, Onno |
|
|
13 |
7 |
p. 568-569 |
artikel |
23 |
Rifampicin and moxifloxacin for tuberculous meningitis – Authors' reply
|
Ruslami, Rovina |
|
|
13 |
7 |
p. 570 |
artikel |
24 |
The power of care
|
Bennet, Neil |
|
|
13 |
7 |
p. 576 |
artikel |
25 |
The pros and cons of probiotics
|
Arnold, Carrie |
|
|
13 |
7 |
p. 571-572 |
artikel |
26 |
The search for an HIV cure: tackling latent infection
|
Kent, Stephen J |
|
|
13 |
7 |
p. 614-621 |
artikel |